[Efficacy and safety of IA regimen containing different doses of idarubicin in de-novo acute myeloid leukemia for adult patients]
[含不同剂量伊达比星的IA方案治疗成人新发急性髓系白血病的疗效和安全性]
期刊:Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
影响因子:
doi:10.3760/cma.j.issn.0253-2727.2017.12.003
Sun, A N; Tian, X P; Cao, X S; Ouyang, J; Gu, J; Xu, K L; Yu, K; Zeng, Q S; Sun, Z M; Chen, G A; Gao, S J; Zhou, J; Wang, J H; Yang, L H; Luo, J M; Zhang, M; Guo, X H; Wang, X M; Zhang, X; Shi, K Q; Sun, H; Ding, X M; Hu, J D; Zheng, R J; Zhao, H G; Hou, M; Wang, X; Chen, F P; Zhu, Y; Liu, H; Huang, D P; Liao, A J; Ma, L M; Su, L P; Liu, L; Zhou, Z P; Huang, X B; Sun, X M; Wu, D P